Metastatic gastric cancer treatment: A little slow but worthy progress

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/27330

Title:	Metastatic gastric cancer treatment: A little slow but worthy progress
Authors:	O'Neil, Bert H. Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı. Kanat, Özkan 55881548500
Keywords:	Oncology Gastric cancer Chemotherapy Targeted treatment Gastroesophageal junction adenocarcinoma Phase-II trial Chemotherapy-naive patients Folinic acid Targeted therapies 1st-line treatment Prognostic model Plus cisplatin Docetaxel Fluorouracil
Issue Date:	Mar-2013
Publisher:	Humana
Citation:	Kanat, Ö ve O'Neil, BH. (2013). "Metastatic gastric cancer treatment: A little slow but worthy progress". Medical Oncology, 30(1).
Abstract:	Metastatic gastric cancer is incurable and remains one of the leading causes of cancer-related deaths around the world. Despite the significant progress in its systemic treatment, metastatic gastric cancer is still a major therapeutic challenge for oncologists. Newer chemotherapy regimens and the addition of molecularly targeted agents to chemotherapy seem to provide better clinical outcomes for patients with metastatic gastric cancer. The objective of this article is to review the current treatment approach for this formidable disease.
URI:	https://doi.org/10.1007/s12032-013-0464-4 https://link.springer.com/article/10.1007/s12032-013-0464-4 http://hdl.handle.net/11452/27330
ISSN:	1357-0560 1559-131X
Appears in Collections:	Scopus Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI